← SynDRA
LEVALLORPHAN
SynDRA canonical compound SYN0024539 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | OPRM1 |
|---|
| Mechanism of action | Opioid antagonist |
|---|
| Indication | respiratory depression |
|---|
| Disease area | pulmonary |
|---|
All known targets
- OPRM1
- CHRNA2
- OPRK1
- Oprd1
- Oprk1
- Oprm1
- Sigmar1
- ache
Mechanisms of action (all sources)
- Opioid antagonist
- OPRM1 ANTAGONIST
- Mu opioid receptor antagonist
- OPRK1 PARTIAL AGONIST
- Kappa opioid receptor partial agonist
- opioid receptor antagonist
- CHRNA2 ANTAGONIST
Drug classes
- Central Nervous System Agents
- Narcotic Antagonists
- Peripheral Nervous System Agents
- Sensory System Agents
Cross-references
Synonyms
- levallorphan tartrate
- lorfan
- naloxiphan
- Levallorphane
- Levalorfano
- Naloxiphan
- Levallofano
- Levallorphanum
- Levallofano [DCIT]
- Levallorphan [INN:BAN]
- Levallorphane [INN-French]
- Levallorphanum [INN-Latin]
- Levalorfano [INN-Spanish]
- Lorfan (TN)
- Ro-1-7700
- N-Allyl-3-hydroxymorphinan
- L-N-Allyl-3-hydroxymorphinan
- Levo-3-hydroxy-N-allyl morphinan
- (-)-3-Hydroxy-N-allylmorphinan
- 17-Allylmorphinan-3-ol
- 17-prop-2-en-1-ylmorphinan-3-ol
- Morphinan-3-ol, 17-allyl-
- Morphinan, 17-allyl-3-hydroxy-
- DTXCID703205
- RefChem:153177
- Morphinan-3-ol, 17-(2-propenyl)-
- CAS-152-02-3
- HSDB 2148
- EINECS 205-799-1
- UNII-353613BU4U
- MCL 113; N-Allyl-3-hydroxymorphinan
- OZYUPQUCAUTOBP-QXAKKESOSA-N
- NCGC00162247-02
- Morphinan-3-ol, 17-allyl-, (-)-
- LEVALLORPHAN [MI]
- LEVALLORPHAN [INN]
- LEVALLORPHAN [HSDB]
- SCHEMBL34060
Look up LEVALLORPHAN in the interactive SynDRA portal →